XOMA Xoma Corp

XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.

$39.05  -0.25 (-0.64%)
As of 04/09/2021 15:54:07 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/19/2012
Outstanding shares:  11,257,756
Average volume:  116,814
Market cap:   $438,939,906
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    98419J206
ISIN:        US98419J2069
Sedol:      BYP7GF0

---

Valuation   (See tab for details)

---

PE ratio:   49.92
PB ratio:   5.07
PS ratio:   14.94
Return on equity:   15.39%
Net income %:   45.25%